Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1994-5-20
|
pubmed:abstractText |
The theoretical and clinical validity of immunochemiluminometric assay of creatine kinase (CK)-MB protein mass was assessed in patients with acute myocardial infarction and the results were compared with those of immunoinhibition assay of CK activity. Serial changes of both CK-MB protein mass and CK-MB activity were analyzed in 20 consecutive patients. In all 312 samples from 20 patients, protein mass and activity of CK-MB showed good correlation. The exponential fitting of the time-value curve of CK-MB protein mass showed a better correlation coefficient than that of CK-MB activity (0.97 +/- 0.02 vs 0.93 +/- 0.07, p < 0.05), indicating that the CK-MB level measured by the immunochemiluminometric assay was less scattered than that measured by the immunoinhibition method. This finding was most evident at lower CK-MB values (< 500 IU/l). The rate of disappearance from serum of CK-MB protein mass was faster than that of CK-MB activity (0.54 +/- 0.23 hr-1 vs 0.28 +/- 0.13 hr-1, p < 0.001). This may indicate that some amount of the CK-MB activity may be inactivated in the early phase of the release into the serum from the necrotic myocardium. Thus, the immunochemiluminometric assay of CK-MB protein mass has superiority in the diagnosis of acute myocardial infarction compared with the immunoinhibition method, especially when the measured CK-MB level is low. This feature may be useful to distinguish a small myocardial infarction from severe ischemia without myocardial necrosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0021-4868
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
717-27
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8164339-Aged,
pubmed-meshheading:8164339-Clinical Enzyme Tests,
pubmed-meshheading:8164339-Creatine Kinase,
pubmed-meshheading:8164339-Female,
pubmed-meshheading:8164339-Humans,
pubmed-meshheading:8164339-Immunoassay,
pubmed-meshheading:8164339-Isoenzymes,
pubmed-meshheading:8164339-Luminescent Measurements,
pubmed-meshheading:8164339-Male,
pubmed-meshheading:8164339-Middle Aged,
pubmed-meshheading:8164339-Myocardial Infarction,
pubmed-meshheading:8164339-Myocardium,
pubmed-meshheading:8164339-Necrosis,
pubmed-meshheading:8164339-Predictive Value of Tests,
pubmed-meshheading:8164339-Time Factors
|
pubmed:year |
1993
|
pubmed:articleTitle |
Creatine kinase-MB protein mass is a better indicator for the assessment of acute myocardial infarction in the lower range of creatine kinase level.
|
pubmed:affiliation |
Division of Cardiology, National Cardiovascular Center, Suita, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|